| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| INCYTE CORP | EVP, Head of US Oncology | Common Stock | 85,252 | $5,187,584 | $60.85 | 15 Jul 2025 | Direct |
| INCYTE CORP | EVP, Head of US Oncology | Performance Shares | 21,923 | 15 Jul 2025 | Direct | ||
| INCYTE CORP | EVP, Head of US Oncology | Employee Stock Option (right to buy) | 19,735 | 15 Jul 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| INCY | INCYTE CORP | 15 Jul 2025 | 3 | $0 | 4 | EVP, Head of US Oncology | 17 Jul 2025, 16:04 |
| INCY | INCYTE CORP | 30 Jun 2025 | 1 | $0 | 4 | EVP, Head of US Oncology | 02 Jul 2025, 16:42 |
| INCY | INCYTE CORP | 06 Jan 2025 | 1 | $0 | 4 | EVP, Head of US Oncology | 08 Jan 2025, 16:11 |
| INCY | INCYTE CORP | 06 Jan 2025 | 0 | $0 | 3 | EVP, Head of US Oncology | 08 Jan 2025, 16:02 |